相似文献
1
Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination.
Br J Cancer. 1975 Dec;32(6):730-6. doi: 10.1038/bjc.1975.284.
2
Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
Cancer Treat Rep. 1977 Jan-Feb;61(1):47-50.
3
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy.
Cancer. 1978 May;41(5):1649-57. doi: 10.1002/1097-0142(197805)41:5<1649::aid-cncr2820410501>3.0.co;2-j.
4
5
6
Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
Arch Intern Med. 1977 Dec;137(12):1711-4.
7
The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
Cancer Clin Trials. 1981 Winter;4(4):363-9.
8
[Combination antimetabolite-alkylating agent-vinblastine in the treatment of advanced breast cancer].
Minerva Med. 1977 Mar 17;68(13):835-7.
9
Five-drug therapy in advanced breast cancer: factors influencing toxicity and response.
Cancer. 1974 Aug;34(2):239-45. doi: 10.1002/1097-0142(197408)34:2<239::aid-cncr2820340202>3.0.co;2-e.
10
Combination chemotherapy in metastatic carcinoma of the breast. Results with a three-drug combination.
Cancer. 1975 Aug;36(2):311-7. doi: 10.1002/1097-0142(197508)36:2<311::aid-cncr2820360204>3.0.co;2-i.
引用本文的文献
1
Single agent versus combination chemotherapy for metastatic breast cancer.
Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003372. doi: 10.1002/14651858.CD003372.pub3.
2
Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer.
Br J Cancer. 2002 Nov 4;87(10):1072-8. doi: 10.1038/sj.bjc.6600626.
3
Oestrogen receptors and response to cytotoxic chemotherapy in advanced breast cancer.
Cancer Chemother Pharmacol. 1980;4(1):43-5. doi: 10.1007/BF00255457.
4
Chemotherapy of breast cancer.
Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139.
5
Efforts to combine endocrine and chemotherapy in the management of breast cancer: do two and two equal three?
Breast Cancer Res Treat. 1983;3(2):117-27. doi: 10.1007/BF01803554.
6
Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group.
Br J Cancer. 1989 Feb;59(2):227-30. doi: 10.1038/bjc.1989.46.
7
Systemic therapy of advanced breast cancer.
Drugs. 1992;44 Suppl 4:17-28; discussion 66-9. doi: 10.2165/00003495-199200444-00003.
本文引用的文献
1
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Ann Intern Med. 1970 Dec;73(6):881-95. doi: 10.7326/0003-4819-73-6-881.
2
Cyclical combination chemotherapy for advanced breast carcinoma.
Br Med J. 1974 Feb 9;1(5901):218-20. doi: 10.1136/bmj.1.5901.218.
3
Proceedings: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer.
Cancer. 1974 Feb;33(2):513-8. doi: 10.1002/1097-0142(197402)33:2<513::aid-cncr2820330228>3.0.co;2-h.
4
Combination chemotherapy with adriamycin (NSC-123127) in metastatic mammary carcinoma.
Cancer Chemother Rep. 1974 Mar-Apr;58(2):251-3.
5
Adriamycin. A new anticancer drug with significant clinical activity.
Ann Intern Med. 1974 Feb;80(2):249-59. doi: 10.7326/0003-4819-80-2-249.
6
Single and combination nonhormonal chemotherapy in breast cancer.
Cancer. 1972 Dec;30(6):1543-55. doi: 10.1002/1097-0142(197212)30:6<1543::aid-cncr2820300621>3.0.co;2-v.
7
Ten years' experience of sterioid assays in the management of breast cancer. A review.
Lancet. 1968 Dec 14;2(7581):1255-60. doi: 10.1016/s0140-6736(68)91757-1.
8
Combination cancer therapy: Presidential address.
Cancer Res. 1972 Dec;32(12):2593-607.
9
L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.
N Engl J Med. 1975 Jan 16;292(3):117-22. doi: 10.1056/NEJM197501162920301.
Zotero 插件